The Essentia Health IRB reviews research projects which involve human subjects and evaluates all components to ensure adequate protection and informed, uncoerced consent.
The Essentia Health IRB processes for the protection of human research participants are guided by federal rules and regulations. The Department of Health & Human Services (HHS) Office for Human Rights Protections (OHRP) oversees the operation of the IRB and the Food and Drug Administration (FDA) enforces regulations for the use of experimental drugs and devices.
The IRB tracks every research project’s progress, even before participants are recruited. Each project is reevaluated at least annually and the IRB works with investigators to modify projects to ensure adequate protection for its participant’s welfare.
The Essentia Health IRB is the IRB charged with reviewing responsibilities for all Essentia Health regions.
The Essentia Health IRB is composed of approximately 20 members representing a diversity of representative capacities and disciplines.
Interoffice Mail 6AV-2
Hours 8 a.m. – 4:30 p.m., Monday-Friday except holidays